TY - JOUR
TI - Thrombectomy for Treatment of Acute Stroke in the COVID-19 Pandemic
AU - Papanagiotou, P.
AU - Parrilla, G.
AU - Creed Pettigrew, L.
JO - Cerebrovascular Diseases
PY - 2021
VL - 50
TODO - 1
SP - 20-25
PB - S Karger AG
SN - 1015-9770, 1421-9786
TODO - 10.1159/000511729
TODO - ferritin;  fibrinogen;  recombinant plasminogen activator, Article;  blood vessel occlusion;  brain infarction;  brain ischemia;  clinical practice;  computer assisted tomography;  coronavirus disease 2019;  emergency ward;  exposure;  hospitalization;  human;  lymphocytopenia;  mechanical thrombectomy;  National Institutes of Health Stroke Scale;  pandemic;  practice guideline;  recanalization;  screening;  thorax radiography;  thrombectomy;  thrombocytopenia;  adult;  aged;  blood;  blood clotting;  complication;  diagnosis;  etiology;  female;  male;  middle aged;  procedures;  risk factor;  surgery;  thrombectomy;  treatment outcome, Adult;  Aged;  Blood Coagulation;  COVID-19;  Embolic Stroke;  Female;  Humans;  Male;  Middle Aged;  Risk Factors;  Thrombectomy;  Treatment Outcome
TODO - This commentary will focus on the role of thrombectomy for the treatment of embolic stroke during the 2019 novel coronavirus disease (COVID-19). We will begin with review of recently promulgated guidelines for use of thrombectomy in COVID-19-associated stroke. We will then survey the reported experience of thrombectomy applied to treatment of large-vessel occlusion (LVO) stroke in COVID-19. We will conclude by discussing unusual challenges confronted by neuro-interventionalists seeking to perform thrombectomy in COVID-19 patients with acute LVO stroke. © 2020 S. Karger AG, Basel. Copyright: All rights reserved.
ER -